Top Markets
Coin of the day
ProMIS Neurosciences, Inc. ProMIS Neurosciences, Inc.

ProMIS Neurosciences, Inc.

PMN
Rangering i aksjer #26785
Based in Toronto, Canada, ProMIS Neurosciences, Inc. focuses on developing... Based in Toronto, Canada, ProMIS Neurosciences, Inc. focuses on developing precise medical solutions for severe neurodegenerative disorders, including Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company employs a unique discovery platform, which incorporates proprietary algorithms like ProMIS and Collective Coordinates, to identify novel, disease-specific targets, known as epitopes, located on the surface of misfolded proteins. The firm's primary product candidates include PMN310, a monoclonal antibody designed to combat toxic oligomers associated with Alzheimer's disease. Another candidate, PMN267, aims to target proteins such as superoxide dismutase 1 and TAR-DNA binding protein 43 relevant to ALS, as well as alpha-synuclein implicated in Parkinson's disease and Lewy body dementia. Additionally, PMN442 is a monoclonal antibody engineered to address toxic alpha-synuclein oligomers and seeding fibrils linked to MSA. Originally established in 2004, the company was known as Amorfix Life Sciences Ltd. before officially adopting the name ProMIS Neurosciences, Inc. in July 2015.
Aksjekurs
$4.40
Sist synkronisert: 2023-07-21
Markedsverdi
$37.78M
Endring (1 dag)
-7.03%
Endring (1 år)
0.00%
Land
CA
Handel ProMIS Neurosciences, Inc. (PMN)

Kategori

Aksjeprishistorikk for ProMIS Neurosciences, Inc. (PMN)
Høyeste sluttskurs: $3.87 den 2023-07-01

Laveste sluttskurs: $70.47 den 2007-10-01
Aksjeprishistorikk for ProMIS Neurosciences, Inc. fra 2007 til 2026
Årlig aksjeprisytelse
År Ytelse
2023 -22.04%
2022 -21.52%
2021 49.13%
2020 -49.02%
2019 -16.16%
2018 -2.72%
2017 52.98%
2016 155.29%
2015 -71.77%
2014 -49.01%
2013 -24.02%
2012 80.59%
2011 -48.53%
2010 -50.72%
2009 192.28%
2008 -73.58%
2007 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
$546.40 38.55%
US
$1.03K 55.80%
NL
$120.74 -14.98%
AU
$142.76 430.90%
US
$757.71 6.46%
CH